Literature DB >> 19801133

Physical fitness in children with end-stage renal disease.

Stuart L Goldstein1.   

Abstract

Medical advances have allowed the majority of children with ESRD to survive into adulthood. As a result, more attention is being focused on improving the health-related quality of life (HRQOL) for children with ESRD. However, most pediatric ESRD HRQOL studies have highlighted on the psychosocial effects of ESRD, with less attention paid to the physical effects. A few studies have recently measured exercise capacity in children with ESRD in the last 5 years. This article reviews studies that detail the physical components of HRQOL as well as other studies that have started to document the exercise capacity of children with ESRD.

Entities:  

Mesh:

Year:  2009        PMID: 19801133     DOI: 10.1053/j.ackd.2009.08.011

Source DB:  PubMed          Journal:  Adv Chronic Kidney Dis        ISSN: 1548-5595            Impact factor:   3.620


  4 in total

Review 1.  Exercise for children with chronic kidney disease and end-stage renal disease.

Authors:  Emma L Clapp; Alan Bevington; Alice C Smith
Journal:  Pediatr Nephrol       Date:  2011-01-14       Impact factor: 3.714

2.  Intradialytic cycling in children and young adults on chronic hemodialysis.

Authors:  Fabio Paglialonga; Amalia Lopopolo; Rosalia Viviana Scarfia; Silvia Consolo; Maria Albina Galli; Simona Salera; Maria Rosa Grassi; Anna Brivio; Alberto Edefonti
Journal:  Pediatr Nephrol       Date:  2013-11-21       Impact factor: 3.714

Review 3.  Physical activity and the 'pediatric inactivity triad' in children living with chronic kidney disease: a narrative review.

Authors:  Thomas J Wilkinson; Lauren L O'Mahoney; Patrick Highton; Joao L Viana; Heitor S Ribeiro; Courtney J Lightfoot; Ffion Curtis; Kamlesh Khunti
Journal:  Ther Adv Chronic Dis       Date:  2022-07-16       Impact factor: 4.970

4.  Kidney transplantation in childhood: mental health and quality of life of children and caregivers.

Authors:  Trond H Diseth; Trine Tangeraas; Trude Reinfjell; Anna Bjerre
Journal:  Pediatr Nephrol       Date:  2011-04-26       Impact factor: 3.714

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.